Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-10T07:16:11.837Z Has data issue: false hasContentIssue false
  • English
  • Français

Gilles de la Tourette's Syndrome

Published online by Cambridge University Press:  02 December 2014

Kia Faridi  and
Oksana Suchowersky
Kia Faridi
Affiliation:
Department of Psychiatry, McGill University, Montreal, QC, Canada
Oksana Suchowersky
Affiliation:
Department of Clinical Neurosciences and Medical Genetics, University of Calgary, Calgary, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Tourette's syndrome (TS) is a childhood onset neurological disorder characterized by motor and vocal tics. It may be associated with a number of co-morbidities including attention deficit hyperactivity disorder, obsessive compulsive symptomatology, and behaviour disorders. Prevalence of TS is higher than previously thought, and may be present in up to 2% of the population. Tourette's syndrome has a significant genetic component. Inheritance may involve several mechanisms including autosomal dominant, bilinear, or polygenic mechanisms. Pathophysiology is still unknown, although is thought to involve striatocortical circuits. Treatment begins with modification of the work and home environment. For more severe cases, medications such as tetrabenazine and neuroleptics may be helpful. Treatment of co-morbidities needs to be considered, as these may result in more disability than the tics themselves.

Résumé

RÉSUMÉ

Le syndrome de Gilles de la Tourette (SGT) est un dérdre neurologique commençt dans l’enfance, caractéséar des tics moteurs et vocaux. Il peut êe associé certaines comorbiditédont le trouble de décit de l’attention/hyperactivitéune symptomatologie obsessive-compulsive et des troubles du comportement. La prélence du SGTest plus évéqu’on ne le pensait et pourrait atteindre 2% de la population. Il existe une composante gétique importante dans le SGT. Le mode d’héditéeut comporter plusieurs ménismes, dont des ménismes autosomiques dominants, biparentaux ou polygéques. Sa physiopathologie est encore inconnue, mais on pense qu’elle implique les circuits striato-corticaux. Le traitement commence par des modifications de l’environnement au travail et àa maison. Dans les cas plus séres, des mécaments tels la téabézine et les neuroleptiques peuvent êe utiles. Le traitement des comorbiditédoit êe envisagéarce qu’elles peuvent êe plus invalidantes que les tics eux-mês.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 30 , supplement S1: A Peer-Reviewed Supplement to the Canadian Journal of Neurological Sciences , February 2003 , pp. S64 - S71
Copyright
Copyright © The Canadian Journal of Neurological 2003

References

1. Marcus, D, Kurlan, R. Tics and its disorders. Neurol Clin 2001; 19:735–758.Google Scholar
2. Leckman, JF, Walker, DE, Cohen, DJ. Premonitory urges in Tourette’s syndrome. Am J Psych 1993; 150:98–102.Google Scholar
3. Bruun, RD, Budman, CL. The course and prognosis of Tourette’s Syndrome. Neurol Clin 1997;15: 291–298.Google Scholar
4. Peterson, BS. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette’s syndrome. J Clin Psych 1996; 57(Suppl 9):24–34.Google Scholar
5. Leckman, JF, Zhang, H, Vitale, A, et al. Course of tic severity in Tourette’s syndrome: the first two decades. Pediatrics 1998; 102:14–19.CrossRefGoogle ScholarPubMed
6. de Groot, CM, Bornstein, RA, Spetie, L, Burriss, B. The course of tics in Tourette’s syndrome: a 5-year follow-up study. Ann Clin Psych 1994;6:227–233.Google Scholar
7. Robertson, MM. Tourette’s syndrome, associated conditions and the complexities of treatment. Brain 2000; 123:425–462.Google Scholar
8. Baron-Cohen, S, Scahill, VL, Izaguirre, J, et al. The prevalence of Gilles de la Tourette’s syndrome in children and adolescents with autism: a large scale study. Psychol Med 1999; 29:1151–1159.Google Scholar
9. Coffey, BJ, Miguel, EC, Biederman, J, et al. Tourette’s disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Mental Disease 1998; 186: 201–206.Google Scholar
10. Cath, DC, Spinhoven, P, van de Wetering, BJ, e.tal The relationship between types and severity of repetitive behaviours in Gilles de la Tourette’s disorder and obsessive-compulsive disorder. J Clin Psych 2000; 61: 505–513.Google Scholar
11. Towbin, KE, Riddle, MA. Attention deficit hyperactivity disorder. In: Hurla, R, (Ed). Handbook of Tourette’s Syndrome and Related Tic and Behavioral Disorders. New York: Marcel Dekker, 1993; 89–109.Google Scholar
12. Apter, A, Pauls, DL, Bleich, A, e.tal An epidemiologic study of Gilles de la Tourette’s syndrome in Israel. Arch Gen Psych 1993; 50:734–738.Google Scholar
13. Knell, ER, Comings, DE. Tourette’s syndrome and attention-deficit hyperactivity disorder: evidence for a genetic relationship. J Clin Psych 1993; 54:331–337.Google Scholar
14. Pauls, DL, Leckman, JF, Cohen, DJ. Familial relationship between Gilles de la Tourette’s syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry 1993; 32:1044–1056.Google Scholar
15. Spencer, T, Biederman, J, Harding, M, e.tal Disentangling the overlap between To urette’s disorder and ADHD. J Child Psychol Psychiatry Allied Disc 1998; 39: 1037–1044.Google Scholar
16. Kurlan, R, Como, PG, Miller, B, e.tal The behavioural spectrum of tic disorders. Neurology 2002; 59: 414–420.CrossRefGoogle ScholarPubMed
17. Voderholzer, U, Muller, N, Haag, C, Riemann, D, Straube, A. Periodic limb movements during sleep are a frequent finding in Gilles de la Tourette’s syndrome. J Neurol 1997;244: 521–526.CrossRefGoogle ScholarPubMed
18. Abwender, DA, Trinidad, KS, Jones, KR, e.tal Features resembling Tourette’s syndrome in developmental stutterers. Brain Lang 1998; 62: 455–464.Google Scholar
19. Abwender, DA, Como, PG, Kurlan, R, e.tal School problems in Tourette’s syndrome. Arch Neurol 1996; 53:509–511.Google Scholar
20. Carter, AS, O’Donnell, DA, Schultz, RT, e.tal Social and emotional adjustment in children affected with Gilles de la Tourette’s syndrome: associations with ADHD and family functioning. Attention Deficit Hyperactivity Disorder. J Child Psychol Psychiatry 2000; 41:215–223.Google Scholar
21. Bawden, HN, Stokes, A, Camfield, CS, Camfield, PR, Salisbury, S. Peer relationship problems in children with Tourette’s disorder or diabetes mellitus. J Child Psychol Psychiatry 1998; 39:663–668.Google Scholar
22. Thibert, AL, Day, HI, Sandor, P. Self-concept and self-consciousness in adults with Tourette’s syndrome. Can J Psychiatry 1995; 40:35–39.Google Scholar
23. Friedrich, S, Morgan, SB, Devine, C. Children’s attitudes and behavioural intentions toward a peer with Tourette’s syndrome. J Pediatr Psychol 1996; 21: 307–319.Google Scholar
24. Champion, LM, Fulton, WA, Shady, GA. Tourette’s syndrome and social functioning in a Canadian population. Neurosci Behav Rev 1988; 12: 255–257.Google Scholar
25. Costello, EJ, Angold, A, Burns, BJ, etal The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psych 1996; 53:1129–1136.CrossRefGoogle ScholarPubMed
26. Hornsey, H, Banerjee, S. The prevalence of Tourette’s syndrome in 13-14 year olds in mainstream schools. J Child Psychol Psychiatry 2001; 42(8): 1035–1039.CrossRefGoogle Scholar
27. Price, RA, Kidd, KK, Cohen, DJ, Pauls, DL, Leckman, JF. A twin study of Tourette’s syndrome. Arch Gen Psych 1985;42:815–820.Google Scholar
28. Hasstedt, SJ, Leppert, M, Filloux, F, van de Wetering, BJ, McMahon, WM. Intermediate inheritance of Tourette’s syndrome, assuming assortative mating. Am J Hum Genet 1995; 57:682–689.Google Scholar
29. Walkup, JT, LaBuda, MC, Singer, HS, etal Family study and segregation analysis of Tourette’s syndrome: evidence for a mixed model of inheritance. Am J Hum Genet 1996; 59:684–693.Google Scholar
30. Seuchter, SA, Hebebrand, J, Klug, B, etal Complex segregation analysis of families ascertained through Gilles de la Tourette’s syndrome. Genet Epidemiol 2000; 18:33–47.Google Scholar
31. Kurlan, R, Eapen, V, Stern, J, McDermott, MP, Robertson, MM. Bilineal transmission in Tourette’s syndrome families. Neurol 1994; 44(12):2336–2342.Google Scholar
32. McMahon, WM, van de Wetering, BJ, Filloux, F, etal Bilineal transmission and phenotypic variation of Tourette’s disorder in a large pedigree. J Am Acad Child Adolesc Psychiatry 1996;35:672–680.Google Scholar
33. Lichter, DG, Dmochowski, J, Jackson, LA, Trinidad, KS. Influence of family history on clinical expression of Tourette’s syndrome. Neurology 1999; 52:308–316.Google Scholar
34. Lichter, DG, Jackson, LA, Schachter, M. Clinical evidence of genomic imprinting in Tourette’s syndrome. Neurology 1995;45:924–928.Google Scholar
35. Eapen, V, O’Neill, J, Gurling, HM, Robertson, MM. Sex of parent transmission effect in Tourette’s syndrome:evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect. Neurology 1997; 48:934–937.Google Scholar
36. Furtado, S, Suchowersky, O. Investigation of the potential role of genetic imprinting in Gilles de la Tourette’s syndrome. Am J Med Genet 1994; 51:51–54.Google Scholar
37. Brett, PM, Curtis, D, Robertson, MM, Gurling, HM. The genetic susceptibility to Gilles de la Tourette’s syndrome in a large multiple affected British kindred:linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase. Biol Psychiatry 1995; 37:533–540.Google Scholar
38. Moriarty, J, Varma, AR, Stevens, J, etal A volumetric MRI study of Gilles de la Tourette’s syndrome. Neurology 1997; 49:410–415.Google Scholar
39. Castellanos, FX, Giedd, JN, Hamburger, SD, Marsh, WL, Rapoport JL. Brain morphometry in Tourette’s syndrome: the influence of comorbid attention-deficit/hyperactivity disorder. Neurology 1996; 47:1581–1583.Google Scholar
40. Hyde, TM, Stacey, ME, Coppola, R, etal Cerebral morphometric abnormalities in Tourette’s syndrome: a quantitative MRI study of monozygotic twins. Neurology 1995; 45:1176–1182.Google Scholar
41. Baumgardner, TL, Singer, HS, Denckla, MB, etal Corpus callosum morphology in children with Tourette’s syndrome and attention deficit hyperactivity disorder. Neurology 1996; 47:477–482.Google Scholar
42. Peterson, BS, Leckman, JF, Duncan, JS, etal Corpus callosum morphology from magnetic resonance images in Tourette’s syndrome. Psych Res 1994; 55:85–99.Google Scholar
43. Mostofsky, SH, Wendlandt, J, Cutting, L, Denckla, MB, Singer, HS. Corpus callosum measurements in girls with Tourette’s syndrome. Neurol 1999; 53:1345–1347.CrossRefGoogle Scholar
44. Zimmerman, AM, Abrams, MT, Giuliano, JD, Denckla, MB, Singer, HS. Subcortical volumes in girls with Tourette’s syndrome:support for a gender effect. Neurology 2000; 54:2224–2229.Google Scholar
45. Moriarty, J, Costa, DC, Schmitz, B, etal Brain perfusion abnormalities in Gilles de la Tourette’s syndrome. Br J Psych 1995; 167:249–254.Google Scholar
46. Riddle, MA, Rasmusson, AM, Woods, SW, etal SPECT imaging of cerebral blood flow in Tourette’s syndrome. In: Chase, TN, Friedhoff, AJ, and Cohen, DJ,(Eds). Advances in Neurology Vol 58. Tourette’s Syndrome: Genetics, Neurobiology, and Treatment. Raven Press, 1992.Google Scholar
47. Klieger, PS, Fett, KA, Dimitsopulos, T, Karlan, R. Asymmetry of basal ganglia perfusion in Tourette’s syndrome shown by technetium-99m-HMPAO SPECT. J Nuclear Med 1997; 38:188–191.Google Scholar
48. Lampreave, JL, Molina, V, Mardomingo, MJ, etal Technetium-99m- HMPAO in Tourette’s syndrome on neuroleptic therapy and after withdrawal. J Nuclear Med 1998; 39:624–628.Google Scholar
49. Braun, AR, Stoetter, B, Randolph, C, etal The functional neuroanatomy of Tourette’s syndrome:an FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology 1993; 9:277–291.CrossRefGoogle Scholar
50. Braun, AR, Randolph, C, Stoetter, B, etal The functional neuroanatomy of Tourette’s syndrome: an FDG-PET Study. II:Relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness. Neuropsychopharmacology 1995; 13:151–168.Google Scholar
51. Biswal, B, Ulmer, JL, Krippendorf, RL, etal Abnormal cerebral activation associated with a motor task in Tourette’s syndrome. Am J Neuroradiology 1998; 19:1509–1512.Google Scholar
52. Peterson, BS, Skudlarski, P, Anderson, AW, etal A functional magnetic resonance imaging study of tic suppression in Tourette’s syndrome. Arch Gen Psych 1998; 55:326–333.Google Scholar
53. Stern, E,Silbersweig, DA, Chee, KY, etal A functional neuroanatomy of tics in Tourette’s syndrome. Arch Gen Psych 2000; 57:741–748.Google Scholar
54. Bergin, A, Waranch, HR, Brown, J, Carson, K, Singer, HS. Relaxation therapy in Tourette’s syndrome:a pilot study. Pediatr Neurol 1998; 18: 136–142.Google Scholar
55. Evers, RA, van de Wetering, BJ. A treatment model for motor tics based on a specific tension-reduction technique. J Behav Ther Exp Psychiatry 1994; 25: 255–260.Google Scholar
56. Shapiro, AK, Shapiro, E, Eisenbraft, GJ. Treatment of Gilles de la Tourette’s syndrome with pimozide. Am J Psychiatry 1983;140:1183–1186.Google Scholar
57. Fulop, G, Phillips, RA, Shapiro, AK, etal ECG changes during haloperidol and pimozide treatment of Tourette’s disorder. Am J Psychiatry 1987;144:673–675.Google Scholar
58. Bruun, RD, Budman, CL. Risperidone as a treatment for Tourette’s syndrome. J Clin Psych 1996; 57:29–31.Google Scholar
59. Robertson, MM, Scull, DA, Eapen, V, Trimble, MR. Risperidone in the treatment of Tourette’s syndrome:a retrospective case note study. J Psychopharmacol 1996; 10:317–320.Google Scholar
60. Gaffney, GR, Gary, R, Perry, JP, etal Risperidone versus clonidine in the treatment of children and adolescents with Tourette’s syndrome; statistical data included. J Am Acad Child Adolesc Psychiatry 2002; 41:330–336.Google Scholar
61. Dion, Y, Annabel, L, Sandor, P, Chouinard, G. Risperidone in the treatment of Tourette’s syndrome:a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002; 22(1): 31–39.Google Scholar
62. Stamenkovic, M, Schindler, SD, Aschauer, HN, etal Effective open-label treatment of Tourette’s disorder with olanzapine. Int Clin Psychopharmacol 2000; 15:23–28.CrossRefGoogle ScholarPubMed
63. Jankovic, J, Glaze, DG, Frost, JD. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette’s syndrome. Neurology 1984;34:688–692.Google Scholar
64. Gilbert, DL, Sethuraman, G, Sine, L, Peters, S, Sallee, FR. Tourette’s syndrome improvement with pergolide in a randomized, doubleblind, crossover trial. Neurology 2000; 54:1310–1315.CrossRefGoogle Scholar
65. Micheli, F, Gatto, M, Lekhuniec, E, etal Treatment of Tourette’s syndrome with calcium antagonists. Clin Neuropharmacol 1990;13:77–83.Google Scholar
66. Sandyk, R. The effects of naloxone in Tourette’s syndrome. AnnNeurol 1985;18:367–368.Google Scholar
67. Muller-Vahl, KR, Schneider, U, Kolbe, H, Emrich, HM. Treatment of Tourette’s syndrome with delta-9-tetrahydrocannabinol. Am J Psychiatry 1999;156: 495.Google Scholar
68. Sanberg, PR, Silver, AA, Shytle, RD, etal Nicotine for the treatment of Tourette’s syndrome. Pharmacol Ther 1997;74: 21–25.Google Scholar
69. Gadow, KD, Nolan, E, Sprafkin, J, Sverd, J. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment. J Dev Behav Pediatr 1995; 16:167–176.Google Scholar
70. Castellanos, FX, Giedd, JN, Elia, J, etal Controlled stimulant treatment of ADHD and comorbid Tourette’s syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 1997;36:589–596.Google Scholar
71. Tourette’s Study Group. Treatment of ADHD in children with tics. Neurology 2002; 58: 527–536.CrossRefGoogle Scholar
72. Singer, HS, Brown, J, Quaskey, S, etal The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome:a doubleblind placebo-controlled study with clonidine and desipramine. Pediatrics 1995; 95:74–81.Google Scholar
73. Scahill, L, Riddle, MA, King, RA, etal Fluoxetine has no marked effect on tic symptoms in patients with Tourette’s syndrome: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 1997; 7:75–85.Google Scholar